- OT
- Industry
- Eyewear and lenses
- Encouraging women to Ad Lib
Encouraging women to Ad Lib
Charmant UK launches four colourful frames inspired by the tropical lotus flower
26 August 2016
Charmant UK has launched four new ophthalmic styles in its Ad Lib collection – a young eyewear brand inspired by trends in fashion, technology, sport and pop culture.
The flowing feminine shapes and colours of the new frames have been inspired by the tropical Lotus flower with ‘its natural appeal and geometric arrangement.’
Designed in France, Ad Lib eyewear is a range aimed at ‘lifestyle-oriented urban women.’
The complete range of 22 styles is made of high-quality titanium material for a light fit and long wearing comfort.
The new full-rim frame ‘AB3239U’ has a soft roundish front shape and comes with a slightly feline accent with a contrasting bi-coloured treatment. The fuchsia and black models have side design elements extended to the front. Other colours available are blue and purple.
Frame ‘AB3240U’ is a roundish, feminine style available in black, brown, red and purple.
The ‘AB3241U’ full-rim frame is offered in brown, fuchsia and purple. It has a soft, square shape that is complemented with a bi-coloured and slightly tapered side design. A design feature is a small gap between the hinge and the side of the frame.
A half-rim style is the new ‘AB3242U,’ which is offered in brown, navy blue, purple and red.
Charmant UK general manager, Louise Brunton, told OT: “Ad Lib is a great range of eyewear created by Charmant. The frames form a beautifully designed, contemporary collection, drawing on Charmant’s world class talent in the production of Titanium eyewear to create something very special.”
Ms Brunton added: “If practices are looking for a quality collection to present to discerning customers then this is it. Ad Lib is also supplied with a range of point-of- sale materials to help promote the eyewear in store.”
For more information, visit the Charmant website.
Advertisement
Comments (0)
You must be logged in to join the discussion. Log in